Table 1.

Relative percentage of icTCRβ+ cells in DN3 and DN4 thymocytes of Gli3+/+, Gli3+/–, and Gli3–/– thymi at day E16.5 and relative percentages of icCD3 high-expressing cells in DN3 and icCD3 intermediate-expressing DN4 subsets of Gli3+/+, Gli3+/–, and Gli3–/– thymi at day E16.5


Genotype

icTCRβ+ DN3 cells relative to wt

icTCRβ+ DN4 cells relative to wt

No. embryos analyzed

icCD3 high DN3 cells relative to wt

icCD3 intermediate DN4 cells relative to wt

No. embryos analyzed
Gli3+/+  1.00 ± 0.06   1.00 ± 0.04   4   1.00 ± 0.1   1.00 ± 0.006   3  
Gli3+/-  0.92 ± 0.03   0.96 ± 0.03   11   1.08 ± 0.072   1.01 ± 0.002   5  
Gli3-/-
 
0.90 ± 0.06
 
0.97 ± 0.05
 
5
 
0.94/1.24*
 
1.016/1.004*
 
2
 

Genotype

icTCRβ+ DN3 cells relative to wt

icTCRβ+ DN4 cells relative to wt

No. embryos analyzed

icCD3 high DN3 cells relative to wt

icCD3 intermediate DN4 cells relative to wt

No. embryos analyzed
Gli3+/+  1.00 ± 0.06   1.00 ± 0.04   4   1.00 ± 0.1   1.00 ± 0.006   3  
Gli3+/-  0.92 ± 0.03   0.96 ± 0.03   11   1.08 ± 0.072   1.01 ± 0.002   5  
Gli3-/-
 
0.90 ± 0.06
 
0.97 ± 0.05
 
5
 
0.94/1.24*
 
1.016/1.004*
 
2
 

Values shown are mean relative percentages ± SE.

*

Two values only for the Gli3-/- genotype in ic CD3 high DN3 and intermediate DN4 cells; therefore, SE is not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal